http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2986467-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3921a924edfe8bec4d11a2064b111640
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3edb9aa141cda1fdc8cb548d0c57f59c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0556
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2016-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1d209e2157906bd45842ae27c160bfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bcf8cfba3b5edb5df0afce114fea6c9
publicationDate 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2986467-C
titleOfInvention Systems and methods for treatment of urinary dysfunction
abstract Methods and systems for providing therapy related to urological disorders are described. Particular embodiments of this technology relate to stimulation of the saphenous nerve (SAFN) either alone or in combination with the posterior tibial nerve (PTN), medial plantar nerve (MPN) or lateral planar nerve. In embodiments nerves are stimulated by percutaneous, transcutaneous, and/or implanted stimulators. In embodiments the SAFN is stimulated below the level of the knee or near the medial malleolus. Embodiments also describe improving nerve stimulation, including SAFN stimulation, using systems and methods termed enhanced transcutaneous electrical stimulation (eTENS) since these enhance the excitation of neural tissue. In an embodiment, systems and methods are provided to increase the chance of providing the selective modulation of specific (targeted) neural substrate, while decreasing the risk of activation of adjacent (non- targeted) nervous tissue.
priorityDate 2015-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423056541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411303255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414883544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22908568

Total number of triples: 31.